Semaglutide

Semaglutide is a GLP-1 receptor agonist used to treat type 2 diabetes and obesity. It lowers blood sugar, reduces appetite, and aids in weight loss. Available as weekly injections (Ozempic, Wegovy) and a daily pill (Rybelsus), it works by mimicking GLP-1 to enhance insulin secretion and slow gastric emptying. Common side effects include nausea and abdominal discomfort.